bullish

McBride

McBride PLC - A strategic, earnings-accretive acquisition

205 Views07 Apr 2026 21:00
Issuer-paid
SUMMARY
  • McBride has announced its proposed acquisition of the complementary Eurotab unit dosing business.
  • The anticipated acquisition price of c.€40m is just 3.1x EBITDA, post significant synergies, and the compelling deal could add c.
  • 6% to FY27E revenues and FY27E Adj. EPS, rising to c.17% in FY29E.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • McBride PLC - A strategic, earnings-accretive acquisition
    07 Apr 2026
x